Rachel McMinn owns 6.72% of Neurogene
1,345,063 shares as of the September 22, 2026 filing, worth $31.3M at the latest close.
NGNE · $465M market cap · Founder-ledGet an email when Rachel McMinn’s stake moves.
Free.
The stake
6.72%
worth $31.3M at the latest close
Stake rank
#963
by dollar value of the stake
Last sale
207 days ago
Mar 26, 2026
Last buy
696 days ago
Nov 22, 2024 · $969,000
Rachel McMinn owns 6.72% of Neurogene Inc.: 1,345,063 of 20,011,382 shares, worth about $31.3M at the 2026-10-16 close. The stake has moved from 13.30% in 2023 to 6.72% on 2026-09-22, across 1 sale and 1 purchase that moved it since 2016. The last trade that moved it was a planned sale of $73,995 on 2026-03-26.
How the stake is held
as of the Sep 22, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Sep 22, 2026 · Form 4 ↗
HELD DIRECTLY
1,345,063
100.0%
THE STAKE
1,345,063
6.72%